"Sizimisele ukwenza umuthi wokugomela i-COVID-19 ukuze uphephe, usebenze futhi ube lula ukuwusebenzisa," kusho uDkt. Kwong, oyiChief Scientific Officer we-DreamTec. Ukusetshenziswa kwe-B. subtilis antibody booster kudonse ukunaka emhlabeni wonke njengoba ingagcinwa endaweni yokushisa yegumbi futhi ihlale izinzile okungenani izinyanga eziyisithupha, njengoba kushiwo kwabezindaba zaseBrithani Clinical Trials Arena. UDkt. Kwong wanezela ukuthi amaprotheni e-spike awangeni egazini.
B. subtilis ikhethwa ngokusekelwe ekhonweni layo lokusinda ezimweni ze-microbiome yamathumbu omuntu ngokwenza izinhlamvu. Kuphinde kuqashelwe i-US Food and Drug Administration (i-FDA) njenge-Generally Recognised As Safe (GRAS). Njengoba ikhono lemithi yokugoma yesintu libukelwa phansi noma nini lapho kukhona okuhlukile, uDkt. Kwong wembula, “Senze izakhiwo zethu zamanje esikhathini esingangezinyanga, ngakho-ke uma kudingeka singenza okufanayo ngokuzayo nabanye okungenzeka bakwa-SARS-CoV-2 okuhlukile, njenge-Omicron.
"Sihlela ukusebenzelana nabalingani bezimboni ukwenza izifundo zangaphambi komtholampilo ukuze kuhlolwe ukukhathazeka kokuphepha kokusetshenziswa kwabantu," kusho uDkt. Kwong. I-DreamTec ibona ngeso lengqondo i-oral antibody booster ekhiqizwa ngezindlela zamaphilisi aqukethe izigidigidi zezinhlamvu ze-B. subtilis. Izinhlamvu ze-transgenic zibe sezikhishwa emathunjini amancane, lapho kukhiqizwa khona impendulo ye-mucosal ethize-immune. Lokhu kuvumela indlela ephephile nesebenzayo kubantu abagonyiwe yokwengeza isivikelo somzimba ku-SARS-CoV-2.
Isungulwe nguDkt. Kwong Wai Yeung, i-DreamTec yinkampani ye-biotechnology ethuthukisa ubuchwepheshe be-biotechnologies obusezingeni eliphezulu okuhlanganisa ukuvezwa kwamaprotheni abalulekile, i-RNA, kanye nokutshalwa kwe-stem cell.
